/
DCF Valuation
Base-case fair value
$42.50
Intrinsic $56.66 · 25% MOS
Current price: $27.10
Base-case summary
Our base-case DCF for AtriCure, Inc. (ATRC) projects 10 years of free cash flow growth at 20.0% for years 1–5 and 10.0% for years 6–10, anchored to 748.6% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $54M in trailing free cash flow, this produces an intrinsic value of $56.66 per share. A 25% safety margin gives a fair value of $42.50, suggesting the stock is currently 57% undervalued against the $27.10 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$54M
Cash & equivalents
$146M
Total debt
$75M
Shares outstanding
49M